GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cormedix Inc (STU:19KA) » Definitions » Cyclically Adjusted PB Ratio

Cormedix (STU:19KA) Cyclically Adjusted PB Ratio : 2.74 (As of Jun. 10, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Cormedix Cyclically Adjusted PB Ratio?

As of today (2024-06-10), Cormedix's current share price is €4.68. Cormedix's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €1.71. Cormedix's Cyclically Adjusted PB Ratio for today is 2.74.

The historical rank and industry rank for Cormedix's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:19KA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.73   Med: 3.79   Max: 15.29
Current: 2.74

During the past years, Cormedix's highest Cyclically Adjusted PB Ratio was 15.29. The lowest was 1.73. And the median was 3.79.

STU:19KA's Cyclically Adjusted PB Ratio is ranked worse than
63.99% of 661 companies
in the Biotechnology industry
Industry Median: 1.75 vs STU:19KA: 2.74

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Cormedix's adjusted book value per share data for the three months ended in Mar. 2024 was €0.971. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.71 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cormedix Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Cormedix's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cormedix Cyclically Adjusted PB Ratio Chart

Cormedix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.84 6.48 3.56 2.80 2.09

Cormedix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.62 2.40 2.14 2.09 2.25

Competitive Comparison of Cormedix's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Cormedix's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cormedix's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cormedix's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cormedix's Cyclically Adjusted PB Ratio falls into.



Cormedix Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cormedix's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=4.68/1.71
=2.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cormedix's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Cormedix's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.971/131.7762*131.7762
=0.971

Current CPI (Mar. 2024) = 131.7762.

Cormedix Quarterly Data

Book Value per Share CPI Adj_Book
201406 -0.268 100.560 -0.351
201409 0.969 100.428 1.271
201412 0.656 99.070 0.873
201503 1.259 99.621 1.665
201506 4.799 100.684 6.281
201509 4.583 100.392 6.016
201512 4.341 99.792 5.732
201603 3.792 100.470 4.974
201606 3.349 101.688 4.340
201609 2.622 101.861 3.392
201612 2.089 101.863 2.702
201703 1.268 102.862 1.624
201706 1.152 103.349 1.469
201709 0.655 104.136 0.829
201712 0.426 104.011 0.540
201803 0.042 105.290 0.053
201806 -0.326 106.317 -0.404
201809 -0.412 106.507 -0.510
201812 0.199 105.998 0.247
201903 0.615 107.251 0.756
201906 0.612 108.070 0.746
201909 1.016 108.329 1.236
201912 0.829 108.420 1.008
202003 0.748 108.902 0.905
202006 0.629 108.767 0.762
202009 0.934 109.815 1.121
202012 1.083 109.897 1.299
202103 1.773 111.754 2.091
202106 1.675 114.631 1.926
202109 1.548 115.734 1.763
202112 1.459 117.630 1.634
202203 1.404 121.301 1.525
202206 1.421 125.017 1.498
202209 1.380 125.227 1.452
202212 1.214 125.222 1.278
202303 1.132 127.348 1.171
202306 0.988 128.729 1.011
202309 1.422 129.860 1.443
202312 1.171 129.419 1.192
202403 0.971 131.776 0.971

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cormedix  (STU:19KA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cormedix Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Cormedix's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cormedix (STU:19KA) Business Description

Industry
Traded in Other Exchanges
Address
300 Connell Drive, Suite 4200, Berkeley Heights, NJ, USA, 07922
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's primary focus is to develop its lead product candidate, DefenCath, for potential commercialization in the United States (U.S.) and other key markets.

Cormedix (STU:19KA) Headlines

No Headlines